๐Ÿ””Stock Alerts via Telegram โ€” Free for All Users

PGNY Stock Risk & Deep Value Analysis

Progyny Inc

Healthcare โ€ข Healthcare Plans

DVR Score

7.9

out of 10

Solid Pick

The Bottom Line on PGNY

We analyzed Progyny Inc using our deep value framework. Sign in to see our full verdict and DVR Score.

We ran PGNY through our deep value framework โ€” analyzing financial health, distress signals, competitive moat, and risk factors. Here's what we found.

Updated Mar 17, 2026โ€ขRun Fresh Analysis โ†’

๐Ÿ“ˆPGNY Performance Overview3yr weekly

๐Ÿ“Š

Unlock PGNY Performance Chart

See 3 years of price history, quarterly revenue trends, and DVR score changes

Weekly adjusted close ยท Quarterly revenue & EPS ยท DVR score history

PGNY Stock Risk Analysis

Overall Risk

Moderate

Financial Risk

Medium

Market Risk

Medium

About Progyny Inc (PGNY)

Sector

Healthcare

Industry

Healthcare Plans

Market Cap Category

small

Market Cap

$1.66B

PGNY Deep Value Analysis

Progyny maintains its robust leadership in the expanding fertility and family-building benefits market, driven by its effective 'Smart Cycle' model and growing network effects. The business model is highly scalable, addressing a significant and underserved TAM within employer-sponsored healthcare. Despite a slight recent price decline, the current $1.43B market cap ($17.42/share) presents an even more compelling entry valuation compared to our last analysis, making the 10x growth target ($14.3B market cap) within 3-5 years more achievable. Management continues to execute on its strategic vision, securing major employer clients and expanding its provider network. While competition and economic headwinds impacting benefit budgets remain risks, the enhanced risk-reward profile at this valuation, combined with a clear path to market dominance, justifies the continued strong score.

PGNY Red Flags & Warning Signs

Premium
  • โš 

    Stronger-than-expected competition from new entrants or large healthcare players (e.g., UnitedHealth, Cigna)

  • โš 

    Economic downturn leading to reduced employer benefit spending or client churn

  • โš 

    Negative regulatory changes impacting fertility coverage or benefit administration

Unlock PGNY Red Flags & Risk Warnings

Premium members see every risk event we found.

๐Ÿ“ˆ

Unlock the full report

Create a free account to see the DVR score, risk flags, and AI analysis.

๐Ÿ”ฅ New Member Exclusive

Unlock everything for $47/yr

$79/yrSave 41%

  • โœ“ Catalysts, bull case, moat & red flags
  • โœ“ Unlimited stock analyses + alerts
  • โœ“ Full database, search & portfolio (50 stocks)
Get Premium โ€” $47/yr

7-day money back ยท Cancel anytime

PGNY Financial Health Metrics

Market Cap

$1.66B

P/E Ratio

32.78

PGNY Competitive Moat Analysis

Premium

Moat Rating

Narrow

Moat Trend

Expanding

Moat Sources

3 Identified

Network EffectsSwitching CostsIntangible Assets/IP

Progyny's moat is strengthening due to its growing network of high-quality providers and increasing employer adoption, which creates significant switching costs for clients and makes it difficult for new entrants to replicate the scale and clinical outcome data. The 'Smart Cycle' model itself, backed by proprietary data, is an intangible asset that improves with more utilization.

PGNY Competitive Moat Analysis

Premium unlocks moat rating, sources & durability.

PGNY Catalysts & Growth Drivers

Near-Term (0-6 months)

  • โ€ขQ1 2026 Earnings Report (estimated late April/early May 2026)
  • โ€ขAnnouncement of significant new employer client wins (Q2 2026)
  • โ€ขExpansion of 'Smart Cycle' services to cover additional family-building options

Medium-Term (6-18 months)

  • โ€ขFurther penetration into the large employer market (Fortune 500 companies)
  • โ€ขPotential strategic partnerships to integrate with broader HR/benefits platforms
  • โ€ขExpansion of provider network into underserved geographic regions

Long-Term (18+ months)

  • โ€ขEstablishment as the dominant, go-to platform for all fertility and family-building benefits
  • โ€ขData monetization opportunities from extensive 'Smart Cycle' outcomes data
  • โ€ขPotential international market expansion beyond current scope

Catalysts & Growth Drivers

Upgrade to Premium to see catalysts

PGNY Bull Case: What Could Go Right

  • โœ“

    Acceleration in new client logos and covered lives, particularly large enterprises

  • โœ“

    Maintenance or expansion of gross margins and progress towards sustainable profitability

  • โœ“

    Evidence of continued high clinical success rates and patient satisfaction via 'Smart Cycle' data

Bull Case Analysis

See what could go right with Premium

๐Ÿ””

Never miss a move on PGNY

Create a free account to set price alerts and get notified on Telegram when PGNY hits your targets.

๐Ÿ“Š Explore More Stock Analysis

Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential.

FAQ

What is the DVR Score for Progyny Inc (PGNY)?

As of March 17, 2026, Progyny Inc has a DVR Score of 7.9 out of 10, placing it in the "Solid Pick" category. This score is generated by our AI-powered deep value analysis framework that evaluates growth potential, financial health, competitive moat, and risk factors.

What is the market capitalization of Progyny Inc?

Progyny Inc's market capitalization is approximately $1.7B. The company operates in the Healthcare sector within the Healthcare Plans industry.

What ticker symbol does Progyny Inc use?

PGNY is the ticker symbol for Progyny Inc. The company trades on the NMS.

What is the risk level for PGNY stock?

Our analysis rates Progyny Inc's overall risk as Moderate. This assessment considers execution risk, market risk, financial risk, competitive risk, and regulatory risk. For a full breakdown, see the risk analysis section above.

What is the P/E ratio of PGNY?

Progyny Inc currently has a price-to-earnings (P/E) ratio of 32.8. This is above the market average, suggesting the stock may be priced for high growth expectations.

How often is the PGNY DVR analysis updated?

Our AI-powered analysis of Progyny Inc is refreshed regularly to incorporate the latest financial data, market conditions, and news. The most recent update was on March 17, 2026.

Important Disclaimer โ€“ Not Financial Advice

Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.

All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor.